WASHINGTON — U.S. health officials announced a proposed rule on Monday that would require food manufacturers to notify the Food and Drug Administration before introducing new ingredients or additives into processed and packaged foods.
What would change
Under the proposed rule, companies would have to document and submit their safety findings for new colours, flavourings, sweeteners and other ingredients, giving the FDA an opportunity to review potential hazards before products reach consumers. The agency said the move would replace a decades-old approach that lets firms decide whether an ingredient is “generally recognised as safe” without notifying regulators.
“Shifting to a mandatory notification system closes a decades-old information gap, giving the FDA the comprehensive visibility needed to enhance postmarket safety,” acting FDA Commissioner Kyle Diamantas told reporters.
The FDA will accept public comments on the proposal for 120 days, signalling that the rule is at the public consultation stage rather than finalised policy.
Why advocates want change
Consumer groups have long criticised the existing framework as a loophole that allowed thousands of ingredients to enter the U.S. food supply without independent agency review. The proposed notification requirement aims to give regulators the documentation they need to assess risks and, where necessary, take action.
“It must also include strong, science-based safety standards and thorough, independent FDA review before chemicals are allowed in our food,” said Melanie Benesh of the Environmental Working Group.
Related work on ultraprocessed foods
Separately, the FDA said it has completed work on the federal government’s first-ever definition of ultraprocessed food, although the agency has not released the language of that definition. The FDA has submitted the definition to the White House for further review.
A formal definition could be a precursor to additional federal research or regulatory actions — such as labelling or other measures — aimed at packaged foods that some public-health experts link with chronic health conditions.
At a glance: What the proposal includes
- Mandatory notification: Companies must notify the FDA before introducing new ingredients or additives.
- Submission of safety findings: Firms expected to provide documentation supporting safety evaluations.
- Public comment period: 120 days for stakeholders to respond to the proposal.
- Ultraprocessed food definition: Completed by the FDA and sent to the White House; details not yet released.
| Item | Current state | Proposed change |
|---|---|---|
| Ingredient approval | Companies self-determine GRAS status; no mandatory notice | Mandatory notification and submission of safety documentation |
| Public input | Variable; many ingredients introduced without FDA review | 120-day comment period on the proposal |
Practical implications for consumers and industry
For shoppers, the proposal promises earlier regulatory visibility into products and ingredients, which could improve the FDA’s ability to detect safety concerns and act after products are marketed. For the food industry, mandatory notification would likely increase transparency and documentation requirements. Some firms already voluntarily submit notifications; the new rule would make that practice compulsory.
The agency’s move also dovetails with growing scrutiny of processed foods. A government-backed definition of ultraprocessed foods could set the stage for future research, nutritional guidance or labelling initiatives, though no specific regulatory steps have been announced.
The FDA’s request for public comment opens a window for manufacturers, consumer groups, scientists and other stakeholders to shape the final rule. How the agency balances industry administrative burdens with calls for independent, science-based review will determine how far the new approach changes the landscape of food safety oversight.
As the consultation period proceeds, Canadians who buy imported U.S. products or follow U.S. regulatory trends may watch the process closely — changes made by the FDA often influence regulators and manufacturers internationally.
